These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 14748356)

  • 1. Benefits of HAART in co-infected patients.
    AIDS Patient Care STDS; 2003 Nov; 17(11):603-4. PubMed ID: 14748356
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines in human immunodeficiency virus-1-infected individuals.
    Tornero C; Alberola J; Tamarit A; Navarro D
    Clin Microbiol Infect; 2006 Jun; 12(6):555-60. PubMed ID: 16700705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of first antiretroviral treatment duration and outcome in HIV, HIV-HBV and HIV-HCV infection.
    Cooper CL; Mills E
    Int J STD AIDS; 2007 Aug; 18(8):546-50. PubMed ID: 17686217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic transplantation in HIV-HCV co-infected patients].
    Gadano A; Aziz H; Macias S; Villamil F
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S70-3; discussion S74-82. PubMed ID: 16862868
    [No Abstract]   [Full Text] [Related]  

  • 6. [Natural history of hepatitis C in patients HIV-HCV monoinfected and co-infected].
    Fainboim H; Galdame O; Jmelnitzky A
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S29-31; discussion S74-82. PubMed ID: 16862852
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selection for treatment of hepatitis C co-infected patients for ].
    Findor J; Bessone F; Corti M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV/hepatitis co-infection.
    Rockstroh J
    J HIV Ther; 2007 Mar; 12(1):1. PubMed ID: 17589388
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between HIV-1 and HCV infections: towards a new entity?
    Winnock M; Salmon-Céron D; Dabis F; Chêne G
    J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
    Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
    Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infections. Some good news about HAART and liver health.
    TreatmentUpdate; 2008; 20(4):8. PubMed ID: 19248274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hepatitis C in patients with response and recurrence and in co-infected patients who had no response].
    Schroder T; Bessone F; Cavallaro S
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S57-9; discussion S74-82. PubMed ID: 16862863
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
    Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
    Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
    Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
    J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.
    Tedaldi EM; Chen L; Markowitz N; Kelly L; Abrams D;
    J Viral Hepat; 2005 Jul; 12(4):414-20. PubMed ID: 15985013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfection with HIV and hepatitis C virus and immune restoration during HAART.
    Manfredi R
    Clin Infect Dis; 2006 Jan; 42(2):298-9. PubMed ID: 16355345
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment: liver disease in the HIV-infected patient--the courage to treat.
    Dieterich DT
    AIDS Read; 2003 Oct; 13(10):500-1. PubMed ID: 14596228
    [No Abstract]   [Full Text] [Related]  

  • 19. HAART attenuates liver fibrosis in patients with HIV/HCV co-infection: fact or fiction?
    Verma S
    J Antimicrob Chemother; 2006 Sep; 58(3):496-501. PubMed ID: 16854955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C management in HIV infection--where is the controversy?
    Dieterich DT
    AIDS Read; 2002 Jan; 12(1):22-3. PubMed ID: 11862657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.